AGENTASTRO.AI Logo

Behind the Journey

Every great path begins with a single step, and ours started with a shared vision to revolutionize the FDA 510(k) approval process through intelligent AI automation.

Our Evolution

The Problem We Saw

Regulatory teams spending months manually searching through fragmented FDA databases, often missing critical insights that could accelerate their approval pathways.

The Problem We Saw

The Spark of Innovation

The Breakthrough

The Impact Today

Meet the Team

Adam J. Smith

Adam J. Smith

Founder - CEO

Adam is a seasoned leader with over 25 years of experience, renowned for building teams and guiding organizations in solving complex challenges.

Dr. Axel Gedeon Mengara

Dr. Axel Gedeon Mengara

Chief Technology Officer

Axel is AI Leader with a PhD and 10+ years of experience specializing in leading the rapid design, development, and deployment of AI products.

Strategic Advisors

Guided by regulatory experts and industry leaders who understand the challenges you face.

Frank Baylis

Frank Baylis

Frank Baylis is leader in medtech and public policy, and currently serving as Executive Chairman of Baylis Medical Technologies.

Lanna Millien

Lanna Millien

Lanna Millien is a seasoned healthcare business leader with over 20 years' experience in pharmaceuticals and medical devices.

Danny Minogue

Danny Minogue

Danny Minogue is pioneering leader in advanced surgical technologies and healthcare innovation with over 40 years of transformative impact in Canada.

Jay Litkey

Jay Litkey

Jay Litkey, a serial SaaS entrepreneur with over 25 years of experience who founded Embotics, currently serves as SVP at Flexera and advisor to AgentAstro.

Your guide to using AgentAstro

AgentAstro is an AI - powered regulatory intelligence platform purpose - built for the MedTech industry.It accelerates the FDA 510(k) process while also supporting upstream activities such as materials selection, design considerations, and early product strategy.

By combining FDA data with a wide range of trusted industry and scientific sources , AgentAstro provides a complete view of regulatory precedent, design implications, and market context.

Instead of free - form text, it produces submission - ready outputs tailored to FDA expectations, while giving teams the intelligence they need to design smarter and plan more strategically.

In short: AgentAstro is both a regulatory assistant and a strategic intelligence tool, helping MedTech companies move faster from concept to clearance.

AgentAstro is built from the ground up for FDA medical device submissions—with data protection as our top priority.

1. Your proprietary data stays yours. Files you upload are encrypted, isolated, and never shared. Unlike general LLMs, your data is never used to train outside models or exposed to other users.

2. Purpose-built for 510(k) submissions. Where general AI tools generate free-form text, AgentAstro produces submission-ready outputs aligned with FDA expectations.

3. Direct FDA integration. AgentAstro continuously pulls from FDA's public databases to surface predicates, timelines, and review decisions—data that general LLMs don't reliably provide.

4. Specialized AI collaboration. Instead of one generic model, AgentAstro uses multiple AIs, each tuned for regulatory tasks, to deliver the most accurate results.

5. Team-ready. Designed for regulatory teams to collaborate in one workspace with shared insights and outputs.

6. Intuitive and built-to-purpose. No prompt-hacking required—professionals can focus on strategy, not workarounds.

7. Expert-informed. Developed alongside regulatory affairs leaders to reflect real-world FDA practice.

In short: AgentAstro keeps your data secure and delivers FDA-ready outputs—something general LLMs can't match.

General-purpose AI tools like ChatGPT can generate text, but they are not designed for regulatory submissions. AgentAstro is purpose-built for MedTech, with advantages that generic AI cannot match:

1. Secure by design — Your proprietary data is encrypted, isolated, and never used to train external models.
2. FDA-specific intelligence — AgentAstro integrates FDA databases and regulatory precedent directly into its workflows.
3. Submission-ready outputs — Instead of free-form text, you get structured tables, justifications, and draft sections aligned with FDA expectations.
4. Specialized AI workflows — Multiple AIs collaborate to handle tasks like predicate mapping, precedent analysis, and regulatory justification.
5. Team collaboration — Built for regulatory teams to share, refine, and align on outputs in one workspace.
6. Expert-informed — Developed with input from regulatory professionals and MedTech leaders to reflect real-world practice.

In short: ChatGPT can write, but AgentAstro can help you clear the FDA.

AgentAstro is designed for MedTech teams at every stage of development, not only during submission prep. It supports:

Regulatory Affairs professionals who need faster, more confident predicate research and submission-ready outputs.
Medical device developers and engineers making upstream decisions on materials, design features, and usability.
Startups and innovators seeking to validate early product concepts against FDA expectations before investing heavily in prototypes.
Consultants and advisors who want a purpose-built AI tool to deliver richer insights and stronger strategies for clients.
Executives and strategy leaders who rely on regulatory intelligence, industry trends, and competitive monitoring to guide investment and product planning.

In short: AgentAstro is for anyone in MedTech who wants to design smarter, move faster, and submit with confidence.

The FDA 510(k) process is complex, slow, and resource-intensive. AgentAstro transforms how MedTech teams approach it by:

Accelerating predicate research — surfacing relevant devices and precedents in minutes instead of weeks.
Delivering order-of-magnitude efficiency gains — cutting preparation time and effort by 10x or more, so teams can move faster with fewer resources.
Improving effectiveness — strengthening submissions with insights into FDA trends, review patterns, and decision-making history.
Supporting upstream design choices — guiding materials selection, usability considerations, and testing approaches before costly mistakes are made.
Enabling smarter planning — providing regulatory intelligence that helps teams anticipate risks, set realistic timelines, and stay aligned with industry expectations.

In short: AgentAstro makes FDA submissions faster, stronger, and more efficient by an order of magnitude—helping MedTech companies design smarter and clear the FDA with confidence.

AgentAstro combines FDA databases with advanced AI workflows to deliver 10x gains in efficiency and effectiveness.

1.Curates and contextualizes FDA data — automatically compiles device information, predicates, and review history.
2.Runs multi-AI workflows — different specialized AI models collaborate to handle tasks like predicate mapping, precedent analysis, and drafting submission-ready content.
3.Generates structured outputs — instead of free-form text, AgentAstro produces tables, justifications, and draft sections aligned with FDA expectations.
4.Supports team collaboration — multiple stakeholders can review, refine, and share insights in one workspace.
5.Protects proprietary data — your uploads are encrypted, isolated, and never used to train outside models, ensuring complete confidentiality.

In short: AgentAstro transforms raw FDA data into secure, submission-ready intelligence—giving MedTech teams an order-of-magnitude advantage over manual work or general AI tools.

AgentAstro is the product of a unique collaboration between MedTech veterans, regulatory professionals, and AI engineers. The idea grew out of a pressing reality: medical device companies spend enormous amounts of time and resources navigating the FDA 510(k) process, yet the tools available to them are either too generic or too risky to trust with sensitive information.

General-purpose AI tools can't guarantee that proprietary data stays private, and many companies are rightly concerned that confidential files might be exposed or reused to train outside models. AgentAstro was designed to solve this problem from the ground up. Proprietary data is always encrypted, isolated, and never used to train external systems—ensuring companies can take advantage of AI without sacrificing security.

Our MedTech advisors bring firsthand experience launching devices and managing the pressures of FDA clearance. Our regulatory professionals ensure that every output reflects real-world submission practices and aligns with FDA expectations. And our AI engineers translate that expertise into secure, specialized workflows that go far beyond what general-purpose AI tools can deliver.

The result is AgentAstro: a platform built at the intersection of regulatory expertise and AI innovation, designed to make the FDA process faster, smarter, and more secure.

AgentAstro offers three subscription tiers designed to fit different needs:

Solo — For individual users or consultants managing occasional submissions.Provides full platform access at an accessible entry point.
Team — For regulatory teams that need consistent access, collaborative workspaces, and deeper insights to support multiple projects.
Enterprise — For high - volume organizations that require advanced support, enhanced security, and custom integrations.

Plans are available on a monthly or annual basis.

In short: whether you’re a solo consultant, a growing team, or a global enterprise, AgentAstro offers a plan built to match your scale and workflow.

Getting started with AgentAstro is simple:

1.Request a demo — Our team will walk you through the platform and show how it can support your regulatory needs.
2.Choose your plan — Select the Solo, Team, or Enterprise subscription that fits your workflow.
3.Onboard quickly — We'll set up your account and provide everything you need to begin using AgentAstro right away.

In short: book a demo, pick a plan, and start accelerating your FDA submissions.